Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 8

Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum]

Authors Anagnostou T, Litzow MR

Received 28 March 2018

Accepted for publication 31 March 2018

Published 11 April 2018 Volume 2018:8 Pages 11—12

DOI https://doi.org/10.2147/BLCTT.S169529


Anagnostou T, Litzow MR. Blood Lymphat Cancer.
2018;8:1–9.

On page 2, Table 1 was incorrectly presented.
 
Read the original article

 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]